JP2004505616A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004505616A5 JP2004505616A5 JP2002508465A JP2002508465A JP2004505616A5 JP 2004505616 A5 JP2004505616 A5 JP 2004505616A5 JP 2002508465 A JP2002508465 A JP 2002508465A JP 2002508465 A JP2002508465 A JP 2002508465A JP 2004505616 A5 JP2004505616 A5 JP 2004505616A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- fragment
- acid sequence
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012634 fragment Substances 0.000 description 9
- 125000003275 alpha amino acid group Chemical group 0.000 description 8
- 108010014251 Muramidase Proteins 0.000 description 3
- 102000016943 Muramidase Human genes 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 101001018100 Homo sapiens Lysozyme C Proteins 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940051921 muramidase Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21670200P | 2000-07-07 | 2000-07-07 | |
| PCT/US2001/021582 WO2002004011A1 (en) | 2000-07-07 | 2001-07-09 | Anti-hiv and anti-tumor peptides and fragments of lysozyme |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004505616A JP2004505616A (ja) | 2004-02-26 |
| JP2004505616A5 true JP2004505616A5 (enExample) | 2008-08-07 |
Family
ID=22808164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002508465A Pending JP2004505616A (ja) | 2000-07-07 | 2001-07-09 | 抗−ｈｉｖペプチド、抗−腫瘍ペプチド、およびリゾチームのフラグメント |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7838275B2 (enExample) |
| EP (1) | EP1303291B1 (enExample) |
| JP (1) | JP2004505616A (enExample) |
| AT (1) | ATE375800T1 (enExample) |
| AU (1) | AU2001278884A1 (enExample) |
| CA (1) | CA2415083A1 (enExample) |
| DE (1) | DE60130994T2 (enExample) |
| WO (1) | WO2002004011A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003246119B2 (en) * | 2002-06-28 | 2008-02-21 | Fuso Pharmaceutical Industries, Ltd. | Anti-HIV agent |
| ITMI20061950A1 (it) * | 2006-10-11 | 2008-04-12 | Therapicon Srl | Effetto antimetastatico in condizioni patologiche delle cellule umane |
| US7846430B2 (en) * | 2007-03-02 | 2010-12-07 | Stefano Ferrari | Composition and method for treating bovine papilloma virus in equine |
| JP5806434B1 (ja) | 2014-02-21 | 2015-11-10 | 国立大学法人東京海洋大学 | ノロウィルス不活化剤及びその製造方法、ノロウィルス不活化方法、ノロウィルス不活化用リゾチーム類の製造方法、ノロウィルス感染の予防薬又は治療薬、並びにノロウィルス不活化用皮膚外用剤 |
| KR102232006B1 (ko) | 2016-12-28 | 2021-03-25 | 디아이씨 가부시끼가이샤 | 분산체 및 그것을 사용한 잉크젯용 잉크 조성물, 광변환층, 및 액정 표시 소자 |
| CN110438106B (zh) * | 2019-08-06 | 2021-03-23 | 北京华韵国丰新材料科技有限公司 | 一种人工设计的纳米溶菌酶和纳米溶菌酶的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5583211A (en) * | 1992-10-29 | 1996-12-10 | Beckman Instruments, Inc. | Surface activated organic polymers useful for location - specific attachment of nucleic acids, peptides, proteins and oligosaccharides |
| US5554501A (en) | 1992-10-29 | 1996-09-10 | Beckman Instruments, Inc. | Biopolymer synthesis using surface activated biaxially oriented polypropylene |
| JPH06211692A (ja) * | 1993-01-21 | 1994-08-02 | Nippon Oil Co Ltd | 免疫増強剤 |
| WO1995009176A1 (en) * | 1993-09-28 | 1995-04-06 | Beckman Instruments, Inc. | Biopolymer synthesis utilizing surface activated, organic polymers |
| AU3307497A (en) * | 1996-06-26 | 1998-01-14 | Antigen Express, Inc. | Immunotherapy by modulation of antigen presentation |
| WO1998026747A2 (en) * | 1996-12-17 | 1998-06-25 | Terman David S | Superantigen based methods and compositions for treatment of diseases |
| GB9907366D0 (en) * | 1999-03-30 | 1999-05-26 | Medical Res Council | Method for expressing proteins |
-
2001
- 2001-07-09 JP JP2002508465A patent/JP2004505616A/ja active Pending
- 2001-07-09 CA CA002415083A patent/CA2415083A1/en not_active Abandoned
- 2001-07-09 AT AT01957109T patent/ATE375800T1/de not_active IP Right Cessation
- 2001-07-09 WO PCT/US2001/021582 patent/WO2002004011A1/en not_active Ceased
- 2001-07-09 DE DE60130994T patent/DE60130994T2/de not_active Expired - Lifetime
- 2001-07-09 US US10/487,259 patent/US7838275B2/en not_active Expired - Fee Related
- 2001-07-09 EP EP01957109A patent/EP1303291B1/en not_active Expired - Lifetime
- 2001-07-09 AU AU2001278884A patent/AU2001278884A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002504491A5 (enExample) | ||
| WO2005115306A3 (de) | Keratin-bindende polypeptide | |
| AU2003264514A1 (en) | Wt1 substitution peptides | |
| EP0528312A3 (en) | Cyclic peptides and use thereof | |
| EP2405015A3 (en) | Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof | |
| DK1025124T3 (da) | Human interferon-alfa-analoge med lav toksicitet | |
| WO1995025749A3 (en) | Eating suppressant peptides | |
| WO2006023665A3 (en) | Il-1 antagonist formulations | |
| UA91820C2 (ru) | Терапевтическое применение вариантов хемокинов | |
| DE68926679D1 (de) | Physiologisch aktives polypeptid, rekombinantes plasmid, rekombinante mikrobielle zellen, medizinisches präparat sowie verfahren zur gewinnung des gereinigten polypeptids | |
| IT1299583B1 (it) | Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica | |
| JP2004505616A5 (enExample) | ||
| ATE481420T1 (de) | Il-21-derivate | |
| WO2004091475A3 (en) | Gaucher disease drugs and methods of identifying same | |
| WO2002081507A3 (en) | Interferon gamma polypeptide variants | |
| WO2004043373A3 (en) | Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme | |
| DE60332425D1 (de) | 5t4-antigen-peptidepitope der mhc klasse ii | |
| JP2004521076A5 (enExample) | ||
| WO2001083722A3 (en) | Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly | |
| AU3739500A (en) | Protease resistant flint analogs | |
| EP1243595A4 (en) | BH4 FUSIONED POLYPEPTIDES | |
| WO2001053324A3 (en) | Novel haptotactic peptides | |
| SE9401480L (sv) | En ny 78-resters polypeptid (NK-lysin) och dess användning | |
| EP1057490A3 (en) | Use of tranexamic acid for the preparation of a human fibrinogen composition | |
| AU2001278884A1 (en) | Anti-hiv and anti-tumor peptides and fragments of lysozyme |